Purpose: To demonstrate the feasibility of in vivo quantitative susceptibility mapping (QSM) in cardiac MRI and to show that mixed-venous oxygen saturation (SvO 2 ) can be measured non-invasively using QSM. Methods: Electrocardiographic-gated multi-echo 2D gradient echo data were collected at 1.5 T from 14 healthy volunteers during successive breath-holds. Phase wraps and fat chemical shift were removed using a graph-cut-based phase analysis and IDEAL in an iterative approach. The large susceptibility range from air in the lungs to blood in the heart was addressed by using the preconditioning approach in the dipole field inversion. SvO 2 was calculated based on the difference in blood susceptibility between the right ventricle (RV) and left ventricle (LV). Cardiac QSM quality was assessed by two independent readers. Results: Nine out of fourteen volunteers (64%) yielded interpretable cardiac QSM. QSM maps showed strong differential contrast between RV and LV blood with RV blood having higher susceptibility values (291.5 6 32.4 ppb), which correspond to 78.3 6 2.3% SvO 2 . Conclusion: In vivo cardiac QSM is feasible and can be used to measure SvO 2 , but improvements in data acquisition are needed.
INTRODUCTION
Mixed-venous oxygen saturation (SvO 2 ) is an important indicator of cardiopulmonary function that is widely used clinically to assess cardiac function in heart failure patients, and to measure shunt fractions in patients with congenital or acquired heart disease (1-3). Currently, conventional measurement of SvO 2 requires an invasive pulmonary artery catheterization procedure (2) (3) (4) and is therefore both challenging and labor-intensive for critically ill patients.
Cardiac MRI has emerged as a promising non-invasive method for measuring SvO 2 . It has been demonstrated that SvO 2 can be calculated based on blood T 2 relaxation, which requires in vitro calibration of blood samples infused with oxygen at different concentrations (5) (6) (7) (8) (9) (10) (11) (12) . This approach is highly dependent on pulse sequence parameters, field strengths, patient blood characteristics (7, 12, 13) , and accurate blood calibration curves (14-16) therefore complicating its clinical applicability (5, 11) . In contrast, magnetic susceptibility is a fundamental property of biomagnetic sources, with blood susceptibility being linearly dependent on the oxyheme concentration in blood. Therefore, a magnetic susceptibility-based oxygenation measurement method would not require calibration (15, 17) or blood withdrawal from patients.
Because of the difference in electron pairing in heme iron caused by oxygen binding, oxyheme is diamagnetic and deoxyheme is paramagnetic (18, 19) . Therefore, blood oxygen saturation (SO 2 ) can be measured using quantitative susceptibility mapping (QSM), which is an advanced phase-based MRI method for measuring the distribution of biomagnetic sources (19) (20) (21) (22) (23) (24) (25) (26) . Furthermore, QSM-based oxygenation quantification has been demonstrated to be feasible in the brain (17, 18, 27, 28) , and QSM has been used to study the mouse heart ex vivo (29) , but it has not yet been applied to in vivo cardiac MRI because of several technical challenges: cardiac and respiratory motion, chemical shift effects from epicardial fat, and a large range in susceptibilities from air in the lungs and surrounding tissue. As known from coronary MRI, electrocardiogram triggering can be used to acquire data in mid-diastole to minimize cardiac motion, and breathhold or navigator can be used to minimize respiratory motion (30, 31) . Recent advancements in QSM precisely account for chemical shift effects using graph cuts (32) , and deal with large range in susceptibility using preconditioning (33) . By combining the knowledge from these advancements, this study aimed to investigate the feasibility of cardiac QSM for chamber blood SvO 2 quantification.
METHODS

Blood Oxygenation Quantification Using QSM
The blood volume susceptibility, x, depends linearly on the oxygen saturation, SO 2 , and can be estimated as follows (17, 18) (ignoring the contribution from blood products other than oxy/deoxyheme):
where H is the heme concentration in blood (in mmol/mL), x deoxyheme is the molar susceptibility of deoxyheme, and x oHb is the susceptibility of oxyhemoglobin. H is a subject-specific physiological parameter that can be measured or estimated. The multiplicative factor of 4 indicates the number of deoxyhemes contained in a fully desaturated deoxyhemoglobin. Let Dx be the blood susceptibility difference between the right ventricle (RV) and left ventricle (LV) measured on QSM, then the difference in blood oxygenation DSO 2 can be calculated as:
The value of H is calculated as (18) (18) . Given the arterial blood oxygen saturation SaO 2 (measured by pulse oximeter), SvO 2 can be estimated as SaO 2 -DSO 2 .
Cardiac QSM Experiments
This human study was approved by the Weill Cornell Medicine IRB committee and written informed consent was obtained from all subjects before imaging. Fourteen volunteers (13 male, 1 female, mean age 31.3 years 6 5.9, age range ¼ 24-45 years, no history of cardiopulmonary disease) underwent a cardiac MRI exam on a 1.5T clinical scanner (GE HD23.0, GE Healthcare, Waukesha, WI; maximum gradient amplitude 33 mT/m, maximum slew rate 120 T/m/s). Subjects were imaged supine using a product 8-channel cardiac phased array coil (four anterior, four posterior elements) for signal reception and vector electrocardiographic gating for cardiac synchronization. Before cardiac QSM, a breath-hold cine 2D balanced steady-state free precession scan was performed in the two-chamber view to determine the subject-specific optimal cardiac trigger delay time between the electrocardiographic trigger and the mid-diastolic diastasis. For cardiac QSM, a breath-hold electrocardiographic-triggered 2D multi-echo fast gradient echo scan was performed in the short-axis view using the following typical imaging parameters: pulse repetition time (TR) ¼ 23 ms, echo time (TE) ¼ 3.6 ms, D TE ¼ 2.2 ms, number of echoes ¼ 8, in-plane resolution % 1.25 Â 1.25 mm 2 , slice thickness ¼ 5 mm, number of slices ¼ 20, interleaved linear view ordering, first-order flow compensation in the readout and slice directions (for the readout direction, flow compensation gradients were applied to the first echo, and subsequent echoes were naturally flow compensated; for the slice direction, flow compensation gradients were applied to the slice-selection gradient), ASSET parallel imaging factor ¼ 1.5, ten views per heartbeat acquired during mid-diastolic diastasis, one slice per breath-hold of approximately 15 s each. To maximize the consistency of respiratory position between imaging slices acquired in separate breath-holds, all subjects were instructed to completely exhale before holding their breath. Figure 1 summarizes the main steps of cardiac QSM computation from the complex multi-echo GRE image data. First, an initial total field map was obtained by voxel-based linear regression on the phase of the complex data obtained at multiple TEs. This field map estimate contains field wraps and includes contributions from fat chemical shift, both of which need to be removed for accurate QSM reconstruction (37) . In this study, an advanced graph-cuts based unwrapping method called SPURS (32) was used in conjunction with the IDEAL water/fat separation algorithm (38, 39) in an iterative manner (37) to accurately remove fat chemical shift. The susceptibility map was then computed from the total field using the recently developed total field inversion (TFI) algorithm (40) . Briefly, this algorithm solves the total field-to-susceptibility source inversion problem by minimizing the following cost function:
QSM Reconstruction and Blood Oxygenation Difference Calculation
where x is the unknown susceptibility map in the whole field of view (FOV), f is the measured total field, d is a dipole kernel, * is a convolution operator, r is a gradient operator, l is a regularization parameter, M G is an edge mask computed from the magnitude image, and w is a weighting factor depending on SNR (w$ SNR). P is a right preconditioner, designed to increase the convergence speed of the algorithm. As in (40), P was a binary mask that was equal to 1 inside the region of interest (ROI) and a larger value P outside outside the ROI. In this study, both the optimal values of P outside ¼ 20 for the background air and lung region, and l ¼ 1000 were empirically determined in one subject by visual inspection of corresponding QSM maps and then fixed for the remaining subjects. For comparison with conventional QSM processing often used in brain imaging, a second set of QSM maps were computed using the PDF algorithm for background field removal (41) and the MEDI algorithm for dipole deconvolution (21) . A manually segmented ROI centered on the heart was used as a data mask in MEDI (that typically produced QSM maps with less artifacts compared to those obtained with a full FOV ROI). For cardiac QSM analysis, the endocardial surfaces of the RV and LV were manually traced on GRE magnitude images. The mean susceptibility difference between RV and LV blood pools was measured, and DSO 2 was calculated using Equation [2] . SaO 2 was measured using pulse oximeter, and SvO 2 was estimated as SaO 2 -DSO 2 . The visual quality of each cardiac QSM map obtained with the TFI algorithm was scored by two cardiologists experienced in reading cardiac MRI using a three-point scale (1 ¼ major artifacts and uninterpretable, 2 ¼ moderate artifacts and reasonable quality, and 3 ¼ minimum artifacts and excellent quality). To correlate the QSM scores with consistency of breath-holds, we quantified spatial slice consistency as follows: two perpendicular long-axis images clearly depicting the heart-lung interface were obtained by reformatting the acquired short axis slices. A simple signal intensity thresholding on these images was used to find the surface curve corresponding to this heart-lung interface. A second derivative along this curve was computed, and the slice inconsistency was defined as the standard deviation of this second derivative curve. A high standard deviation corresponded to a greater slice inconsistency (less smooth heart-lung interface). The Wilcoxon rank-sum test with Bonferroni correction was used to assess the statistical differences in slice inconsistency among the three groups of QSM scores. Cardiac R2 * maps were also calculated using ARLO (42) , and the average blood R2 * values were measured in the RV and LV using the same endocardial segmentations used in QSM analysis.
RESULTS
The average scan time of cardiac QSM was 11.7 6 1.9 min. The average heart rate was 64.9 6 4.7 beats per minute. All subjects were able to maintain good breathholding during data acquisition for individual slices, leading to excellent GRE images free of motion artifacts (Figs. 2-4) . However, the consistency of end-expiratory breath-holding position between consecutive slices was variable among the subjects, this can be seen as slice misregistration on the long-axis reformatted images (Fig. 4) . Of the 14 acquired cardiac QSM maps, 4 (29%) had excellent image quality (score ¼ 3), 5 (36%) were reasonable (score ¼ 2), and remaining 5 (36%) had significant artifacts and were uninterpretable (score ¼ 1). This resulted in a success rate of 64% (9/14, defined by scores !2). The average SaO 2 measured using pulse oximeter was 98.7%. The measured RV-to-LV susceptibility differences for QSM maps obtained with TFI with image quality scores of 1, 2, and 3 were 188.6 6 64.9 ppb, 266.1 6 22.2 ppb, and 323.3 6 14.6 ppb, respectively. The corresponding values for QSM obtained with the conventional PDFþMEDI method were 98.1 6 18.3 ppb, 122.6 6 43.5 ppb, and 156.1 6 54.2 ppb, respectively. The corresponding SvO 2 values were 85.6 6 4.6%, 80.1 6 1.2%, and 76.0 6 1.1% for TFI versus 93.2% 6 1.28%, 91.4% 6 3.0%, and 89.1% 6 3.8% for PDFþMEDI. The average RV-to-LV susceptibility difference for score !2 was 291.5 6 32.4 ppb (vs. 136.0 6 48.3 ppb for PDFþMEDI), which corresponds to a SvO 2 of 78.3% 6 2.3% (vs. 90.5% 6 3.4% for PDFþMEDI). The values obtained with TFI were in line with the normal range of SvO 2 in healthy adults at approximately 60-80%, while PDFþMEDI yielded values well above this range. There was weak contrast between LV myocardium and LV arterial blood on QSM (Figs. 2 and 3 ) with an average LV blood versus myocardium susceptibility difference of 43.2 6 32.5 ppb measured on the TFI-derived QSM maps with a score !2, and 30.1 6 17.8 ppb measured on the PDFþMEDI-derived QSM maps (p ¼ 0.44, paired t-test). The average slice inconsistency (in pixels) was 2.15, 1.12, and 1.00 for datasets that produced QSM with image scores of 1, 2, and 3, respectively. There was a significant difference in slice inconsistency between QSMs with quality score of 1 and 2 (p ¼ 0.016) and between those with score of 1 and 3 (p ¼ 0.016). The average RV R2 * value across subjects and arterial (diamagnetic) blood. In Figure 3 , a case with a score of 2 shows a similar increase in susceptibility from LV to RV, although there are more apparent streaking and noise artifacts as compared to the cases shown in Figure 2 . Figure 4 shows an example of a failed QSM map with a score of 1, in which major artifacts are present, resulting in poor or physiologically not meaningful RV-to-LV contrast. Figure 5 shows the comparison of the R2 * map, the QSM map obtained with PDFþMEDI, and the QSM map obtained with TFI in one volunteer. In this example, compared to the R2 * map, both of the QSM maps shows improved visual contrast between RV and LV blood. Both QSM maps are free of streaking artifacts, but TFI yielded a realistic SvO 2 of 77.0%, while the PDFþMEDI value was 90.1%, which was well outside the normal range in healthy subjects.
DISCUSSION
Our preliminary data in healthy volunteers showed that in vivo cardiac QSM is feasible but requires improvements in data acquisition to increase success rate and improve QSM quality. The difference in QSM between LV and RV blood can be used to indicate the changes in oxygenation between systemic and venous blood, however, there is little QSM contrast between LV blood and myocardium in healthy subjects.
In this study, the average SvO 2 values derived from the susceptibility maps of healthy volunteers were found to be in reasonable agreement with those reported in the literature. For successful QSM scans (image score ! 2), the average SvO 2 was approximately 78%, which falls in the high end of the normal range (60-80%) (4), indicating an underestimation of susceptibility difference between RV and LV blood. This underestimation may be attributed to the fairly large voxel size (particularly in the slice direction) (43) , which is needed to keep the scan time reasonably short. Another potential factor is the gradual decrease of arterial blood oxygenation in the LV during the length of the breath-hold (44) . Lastly, the hematocrit values of 0.45 for adult male and 0.4 for adult female were assumed for SvO 2 calculation, which might need to be adjusted for individual subjects.
Normal myocardium is weakly diamagnetic and therefore appears isointense with oxygenated LV blood on QSM. This image feature may potentially enable cardiac QSM to detect pathological conditions that alter myocardial tissue properties. For example, intramyocardial hemorrhage is a known consequence of acute myocardial infarction that has been associated with adverse LV chamber remodeling and poor clinical outcomes (45, 46) . Given that hemorrhage would be expected to cause myocardium to become highly paramagnetic (47) , both diagnosis and quantification could potentially be well-addressed by QSM. QSM has been used to measure intracerebral hemorrhage and differentiate intracerebral hemorrhage from calcification (48) . Whereas intracerebral hemorrhage risk has limited cerebral revascularization treatment to just 1-8% of ischemic stroke patients (49) , intramural hematoma damage to the heart as a longterm causal factor for systolic heart failure after acute myocardial infarction is becoming more recognized (45, 46) .
Although QSM is an established technique for mapping tissue and blood susceptibilities in the brain (19) (20) (21) (22) (23) 25, 27, 48, 50) , this technology has not been applied to the chest because of several technical challenges. A major challenge common to heart imaging is respiratory and cardiac, which produce blurring and ghosting artifacts. In this first cardiac QSM study, a short breath-hold of 15 s was used to suspend respiration during acquisition, and data sampling was timed to the mid-diastolic cardiac rest period to minimize cardiac motion. In our cohort of healthy volunteers with good breath-holding ability and low heart rate (65 beats per minute on average), individual GRE image slices with excellent image quality could be obtained. However, significant variability in QSM maps was observed (Figs. 2-4) , and cardiac QSM was deemed successful in only 64% of subjects. This low success rate could be explained by the spatial inconsistency between consecutive slices that were acquired in different breath-holds. This misregistration artifact is best visualized in the long-axis view (Fig. 4) . Misregistration can lead to major errors such as artificial field discontinuities in the field map estimation, which propagate into the final QSM, ultimately leading to severe artifacts. Our results demonstrated that as the slice inconsistency increased, the resulting QSM quality decreased. Spatial misregistration between imaging slices can be a greater problem in older patients with cardiopulmonary diseases who have limited breath-holding capabilities (51) . Slice inconsistency is not a challenge for R2 * -based oxygenation measurement methods that are voxel-based. One approach to overcoming the challenge from respiratory motion in cardiac QSM is to use a free-breathing navigator GRE acquisition (31) , which will be a main focus of our future work.
FIG. 5. Comparison of R2
* map, and QSM maps computed using PDFþMEDI and TFI algorithms. In this example, both QSM maps demonstrated a much improved blood contrast between the right and left ventricles than the R2 * map does. Between the two QSM maps, the result from TFI has better RV-to-LV contrast. The susceptibility difference between RV and LV blood was 327.4 ppb (corresponding to 77.0% SvO2) with TFI, and 138.6 ppb (90.1% SvO2, well above the normal range) with PDFþMEDI.
In addition to the motion challenge during cardiac QSM acquisition, the quality of cardiac QSM depends on the ability of the post-processing algorithm to successfully remove the chemical shift effect of epicardial fat and accurately search through the large susceptibility range from near zero susceptibility sources of heart tissue and very high susceptibility sources of air in the lungs. In this study, a novel algorithm based on SPURS (32) and IDEAL (38) was used in an iterative chemical shift update scheme (37) to improve the quality of the field map in the fat regions (Fig. 1) . To address the large susceptibility range, current state-of-the-art QSM methods generally perform background field removal first to estimate the local field from which QSM is obtained through dipole field inversion. However, this two-step approach fundamentally contains errors in estimating background field from inaccurate boundary conditions (19, 52) , and these errors tend to carry over to the dipole inversion step resulting in errors in the final QSM. In this work, the large susceptibility range is systematically managed using the preconditioning approach with TFI, which has been shown to be better than the background field removal methods at the interface between weak and strong susceptibility sources (40) . As illustrated in Figure  5 , we found that TFI yielded SvO 2 measurements within the expected range, while PDFþMEDI produced unusually high values well above the range expected from healthy volunteers. This strongly suggests that TFI is a more robust algorithm for cardiac QSM. While a simple binary mask was used for preconditioning in the TFI algorithm implemented in this study, a more complex preconditioner that relies on knowledge of strong susceptibility sources inside an ROI (i.e., RV blood, fat, bone, and possibly hemorrhage) may further improve QSM quality.
This initial feasibility study of cardiac QSM has several limitations. First, the current 2D approach uses relatively thick slices (5-mm) and still requires a long scan time (over 10 min). The need for sustaining a consistent breathholding over this extended period precluded the recruitment of cardiac patients who often have limited breathholding capability. Potential approaches for accelerating cardiac QSM include the use of more efficient echo planar readout (53) , parallel imaging (54), and echo sharing (55) , as well as recent image reconstruction methods that combine k-space undersampling with compressed sensing (56) . Second, the in vivo blood oxygenation difference between RV and LV obtained with QSM was not compared with the reference blood sampling method. Third, flow compensation was performed only in the readout and slice directions, which was needed to keep TR and the corresponding breath-hold length short. However, a previous study (27) showed that 3D flow compensation can significantly improve the accuracy of QSM in regions with flow. Furthermore, the blood flow pattern in heart chambers during the mid-diastolic LV filling is complex, potentially resulting in phase errors that cannot be corrected with first-order flow compensation. As a result, the ventricular blood QSM values may have been affected by residual phase shift as a result of incomplete flow nulling, which may explain the slight increase in susceptibility of the LV blood in the apex compared to that at the basal slice (Figs. 2 and 3) . Finally, it has been reported that 2D slice interleaved GRE acquisitions may produce inter-slice phase errors that can be corrected (53, 57, 58) . We have carefully examined our GRE phase data and did not observe such errors, possibly because this study used a single slice 2D acquisition (without slice interleaving). However, phase inconsistency remains a potential concern regarding data acquisition.
CONCLUSIONS
In this work, we demonstrated for the first time the feasibility of in vivo cardiac QSM and showed that a reasonable SvO 2 value can be measured non-invasively using this method.
